Isn't PHK still selling at a ~25% premium to NAV? It doesn't seem like it's a buy until we get to ~$6/share or less, no?
Also true. There's more than one way to win, but that 6% divi is a big help to retirees.
The£19-a-share cash offer represents an approximately 35% premium to the £14 price I saw in an article that mentioned this possibility recently. That might put it a little closer to $60/share. Either way, I wouldn't complain but I'd miss that hefty dividend from GSK that we wouldn't be getting from the tightwads at Pfizer.
Another attack on coal by Obama reported in today's New York Times, but even if this plan loses in court cases, it will still cast a pall over the industry for a long time. I would expect more downward pressure on coal company stock prices, even ARLP's.
She seems to know whereof she speaks. Maybe this will help the stock on Monday.
The above from a Barron's article this week. Maybe between this endorsement, from someone who seems to know whereof she speaks, and GSK's malaria drug, we can get a small bounce on Monday.
Google the title to get to the Seeking Alpha article. What does anyone think about the conclusion? Granted, the suggestion of a dividend cut is still speculative, and Oppenheimer analysts aren't so pessimistic, but where there's smoke...
Google the title. Article posted at Nasdaq site.